MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
Michael C MithoeferAllison A FeducciaLisa JeromeAnne MithoeferMark WagnerZach WalshScott HamiltonBerra Yazar-KlosinskiAmy EmersonRick DoblinPublished in: Psychopharmacology (2019)
ClinicalTrials.gov Identifier: NCT00090064, NCT00353938, NCT01958593, NCT01211405, NCT01689740, NCT01793610.